Mark Peterson
Reading the market’s next move: deconstructing the deals and disruptions that move the world.
About This Column
Mark Peterson is an analyst of the maneuvers that redefine global industry. Formerly the voice behind Strategic Transactions & Market Disruptors, Mark has expanded his lens to investigate how high-stakes deals serve as the ultimate signals of future market dominance. He specializes in deconstructing the "why" behind corporate maneuvers - dissecting M&A activity, IPOs, and strategic realignments to uncover what they telegraph about the next decade of growth and competition. His column is a destination for those who want to understand the intersection of capital, technology, and the evolving corporate landscape.
Displaying items 321-340 of 560 in total
FDA Clears First Trial to Reverse Cellular Aging in Human Eyes
Limy Raises $10M to Master the 'Agentic Web' for Global Brands
China Revives Ancient Legend of Xu Fu as a Bridge to Japan and Korea
New Gold, Coeur Mining Merger Wins Overwhelming Shareholder Approval
Real Estate Brokerages Signal Major Financial Health Rebound
Global Shipping at a Crossroads: Leaders Convene in Athens to Chart Future
New Law Ends Housing Penalty for Disabled Veterans
Cloudbrink Unveils Safe AI to Secure the Hybrid Workforce's AI Frontier
Atmosphera Taps Veteran COO to Scale Climate-Curated Beauty Brand
SpotDraft Lands $8M from Qualcomm to Pioneer On-Device Legal AI
Blue Gold Mints First Digital Coins, Betting on Trust and Transparency
The End of Focus: Modern Workdays Now Have Only 2-3 Deep Work Hours
Marvion's Stock Swap: Growth Fuel or Shareholder Gamble?
Fatality at Brazil Gold Mine Casts Shadow on Serabi's Expansion
Fury Gold Taps Veteran Phillips Baker to Steer Path to Production
AI Voice Assistant Ava Aims to Solve Hotel Staffing and Revenue Crisis
Artlist Bets on AI With End-to-End Video Production Ecosystem
Flowflex Launches First FDA-Cleared 4-in-1 Home Test for RSV, Flu, COVID
FDA Greenlights Novel Eye Pain Drug for Compassionate Use
